Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 133, Issue 4, 2006, Pages 382-388

  Van Der Velden, Vincent H J ^a   Hoogeveen, Patricia G ^a   Pieters, Rob ^a   Van Dongen, Jacques J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukaemia; Bone marrow; Minimal residual disease; RQ PCR; Sampling

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE REARRANGEMENT; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PEDIATRICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BONE MARROW EXAMINATION; CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 33645834105     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06056.x     Document Type: Article

References (21)

1. Bruggemann M. Van der Velden V.H.J. Raff T. Droese J. Ritgen M. Pott C. Wijkhuijs A. Goekbuget N. Hoelzer D. Van Wering E.R. Van Dongen J.J.M. Kneba M. 2004 Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease (MRD) in childhood and adult T-cell acute lymphoblastic leukemia (T-ALL) Leukemia 18 709 719
2. Cave H. Van der Werff ten Bosch J. Suciu S. Guidal C. Waterkeyn C. Otten J. Bakkus M. Thielemans K. Grandchamp B. Vilmer E. 1998 Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group New England Journal of Medicine 339 591 598
3. Coustan-Smith E. Sancho J. Hancock M.L. Boyett J.M. Behm F.G. Raimondi S.C. Sandlund J.T. Rivera G.K. Rubnitz J.E. Ribeiro R.C. Pui C.H. Campana D. 2000 Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia Blood 96 2691 2696
4. Goulden N. Bader P. Van der Velden V. Moppett J. Schilham M. Masden H.O. Krejci O. Kreyenberg H. Lankester A. Revesz T. Klingebiel T. Van Dongen J. 2003 Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia British Journal of Haematology 122 24 29
5. Jansen N.C. Kingma A. Tellegen P. van Dommelen R.I. Bouma A. Veerman A. Kamps W.A. 2005 Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research Archives of Disease in Childhood 90 301 304
6. Martens A.C. Schultz F.W. Hagenbeek A. 1987 Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease Blood 70 1073 1078
7. Panzer-Grumayer E.R. Schneider M. Panzer S. Fasching K. Gadner H. 2000 Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia Blood 95 790 794
8. Pongers-Willemse M.J. Seriu T. Stolz F. d'Aniello E. Gameiro P. Pisa P. Gonzalez M. Bartram C.R. Panzer-Grumayer E.R. Biondi A. San Miguel J.F. Van Dongen J.J.M. 1999 Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia Leukemia 13 110 118
9. Schrappe M. 2002 Risk-adapted therapy: lessons from childhood acute lymphoblastic leukemia Hematological Journal 3 127 132
10. Szczepanski T. Willemse M.J. Van Wering E.R. Van Weerden J.F. Kamps W.A. Van Dongen J.J.M. 2001 Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14 Leukemia 15 1415 1423
11. Szczepanski T. Flohr T. Van der Velden V.H.J. Bartram C.R. Van Dongen J.J.M. 2002 Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia Best Practical Research and Clinical Haematology 15 37 57
12. Szczepanski T. Van der Velden V.H.J. Hoogeveen P.G. De Bie M. Jacobs D.C.H. Van Wering E.R. Van Dongen J.J.M. 2004 Vδ2-Jα gene rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells Blood 103 3798 3804
13. Van der Velden V.H.J. Wijkhuijs J.M. Jacobs D.C. Van Wering E.R. Van Dongen J.J.M. 2002a T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis Leukemia 16 1372 1380
14. Van der Velden V.H.J. Willemse M.J. Van der Schoot C.E. Hahlen K. Van Wering E.R. Van Dongen J.J.M. 2002b Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR Leukemia 16 928 936
15. Van der Velden V.H.J. Hochhaus A. Cazzaniga G. Szczepanski T. Gabert J. Van Dongen J.J.M. 2003 Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects Leukemia 17 1013 1034
16. Van Dongen J.J. Seriu T. Panzer-Grumayer E.R. Biondi A. Pongers-Willemse M.J. Corral L. Stolz F. Schrappe M. Masera G. Kamps W.A. Gadner H. Van Wering E.R. Ludwig W.D. Basso G. de Bruijn M.A. Cazzaniga G. Hettinger K. Van der Does-van den Berg A. Hop W.C. Riehm H. Bartram C.R. 1998 Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 352 1731 1738
17. Van Dongen J.J.M. Langerak A.W. Bruggemann M. Evans P.A.S. Hummel M. Lavender F.L. Delabesse E. Davi F. Schuuring E. Garcia Sanz R. van Krieken J.H.J.M. Droese J. Gonzalez D. Bastard C. White H.E. Spaargaren M. Gonzalez Diaz M. Parreira A. Smith J.L. Morgan G.J. Kneba M. Macintyre E.A. 2003 Design and standardization of PCR primers and protocols for detection of clonal immunogloulin and T-cell receptor gene recombinations in suspect lymphoproliferations Leukemia 17 2257 2317
18. Van Wering E.R. Van der Linden-Schrever B.E. Van der Velden V.H.J. Szczepanski T. Van Dongen J.J.M. 2001 T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies Leukemia 15 1301 1303
19. Verhagen O.J. Wijkhuijs A.J. Van der Sluijs-Gelling A.J. Szczepanski T. Van der Linden-Schrever B.E. Pongers-Willemse M.J. Van Wering E.R. Van Dongen J.J.M. Van der Schoot C.E. 1999 Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques Leukemia 13 1298 1299
20. Verhagen O.J. Willemse M.J. Breunis W.B. Wijkhuijs A.J. Jacobs D.C. Joosten S.A. Van Wering E.R. Van Dongen J.J.M. Van der Schoot C.E. 2000 Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia Leukemia 14 1426 1435
21. Willemse M.J. Seriu T. Hettinger K. d'Aniello E. Hop W.C. Panzer-Grumayer E.R. Biondi A. Schrappe M. Kamps W.A. Masera G. Gadner H. Riehm H. Bartram C.R. Van Dongen J.J.M. 2002 Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL Blood 99 4386 4393